What is the risk of disease caused by Legionella in the Czech Republic?
Authors:
M. Petrovová
Authors‘ workplace:
Přednosta: prof. MUDr. Petr Brhel, CSc.
; Klinika pracovního lékařství LF MU a Fakultní nemocnice u svaté Anny v Brně
Published in:
Prakt. Lék. 2012; 92(4): 209-213
Category:
Of different specialties
Overview
The article gives a short overview of the current clinical, diagnostic and therapeutic knowledge of Legionnaires disease and about the possible risk exposures and methods of prevention. Between 1998 and 2008 the National Legionella Reference Laboratory in the Czech Republic found a high percentage of hotels, spa hotels, hospitals, and cooling towers colonized with Legionella (60-89%). The numbers of reported cases of legionellosis in the same period had a consistently increasing trend with a peak in 2008 (n = 15). In 2011, the number of reported cases rose four times (n = 58). In the years 2000-2010 14% of legionellosis was reported in association with travel, 9% was contracted from healthcare facilities and 3% from the workplace. The origin of the remaining 74% of cases has not been explained. There were only sporadic cases of disease, community or industrial clusters or outbreaks have not yet been detected in the Czech Republic. There are an increasing number of people with risk factors and an increased exposure to Legionella in living spaces, medical facilities, sports and shopping centres or an occupational connection.
Key words:
legionellosis, Legionnaires’ disease, Pontiac fever, Legionella pneumophila, epidemiology.
Sources
1. Bartram, J.Y. Chartier, Lee J., et al. Legionella and the prevention of legionellosis. Geneva, Switzerland: World Health Organization Press, 2007. ISBN 9241562978.
2. Schurmann, D., Grosse. G., Horbach, I., Fehrenbach, F.J. Pulmonary and extrapulmonary manifestation of L. pneumophila. Zentralbl Bacteriol Mikrobiol Hyg (A), 1983, 255(1), 120–126.
3. Jarešová, M., Stříž, I., Hložánek, I. Legionella – bakterie ohrožující imunosuprimované pacienty po orgánových transplantacích. Alergie, 2000, 2(4), s. 128–130.
4. Turzíková, J., Fuchs, M., Pohunek, P., Nechanický P. Legionella pneumophilla – původce pneumonie v dětském věku. Alergie, 2000, 2(2), s. 128–130.
5. Pedro-Botet, ML., Nunez, R., Sopena, N., et al. Legionella pneumonia (LP) in immunosuppressed (IS) patients. Abstractbook. The 7th International Conference Legionella 2009. Institute Pasteur: Paris, France, 2009.
6. Waterer, G.W., Baselski, V.S., Wunderink, R.G. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician’s viewpoint. Am J Med., 2001, 110(1), p. 41–48.
7. Edelstein, P.H. Detection to antibodies to Legionella. In: Rose AR, Conway de Macario E, Fahey JL, Friedman P, Penn GM (eds.). Manual of clinical immunology, 4th ed. Washington D.C.: American Society for Microbiology 1992, p. 459–466.
8. Blyth, C.C., Adams, D.N., Chen, S.C. Diagnostic and typing methods for investigating Legionella infection. N S W Public Health Bull., 2009, 20(9–10), p. 157–161.
9. Mahbubani MH, Bej AK, Miller R, et al. Detection of Legionella with polymerase chain reaction and gene probe methods. Mol Cell Probes, 1990, 4(3), p. 175–187.
10. Haroon, A., Koide, M., Higa, F., et al. Identification of Legionella pneumophila serogroups and other Legionella species by mip gene sequencing. J Infect Chemother., 2011, October 2011. [Epub ahead of print] DOI: 10.1007/s10156-011-0324-0. ISSN 1437-7780.
11. Edelstein, P.H. Antimicrobial therapy for Legionnaires’ disease, still in need of improvement. Abstractbook, The 7th International Conference Legionella 2009. Institute Pasteur: Paris, France, 2009.
12. Jindrák, V. Strategie antibiotické léčby těžké komunitní pneumonie v intenzivní péči. Anest. intenziv. Med., 2003, 14(6), p. 291–294.
13. Drašar, V., Polcar, R., Fry, N.K. Legionella colonization of czech environment and its health risk. A ten year study. Abstractbook. The 7th International Conference Legionella 2009. Institute Pasteur: Paris, France, 2009.
14. Piana, A., Azara, A., Sotgiu, G., et al. Travel-associated Legionellosis: emerging illness or epidemiological reality? Ig Sanita Pubbl., 2006, 62(3), p. 305–318.
15. Carol, J. Legionnaires’ disease in Europe 1995–2008: Trends and Challenges. Abstractbook. The 7th International Conference Legionella 2009. Paris, France: Institute Pasteur, 2009.
16. Roig, J., Sabria, M., Pedro-Botet, M.L. Legionella spp.: community acquired and nosocomial infections. Curr Opin Infect Dis., 2003, 16(2), p. 145–151.
17. Sabria, M., Yu, V.L. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect Dis., 2002, 2(6), p. 368–373.
18. Singh, T., Coogan, M.M. Isolation of pathogenic Legionella species and legionella-laden amoebae in dental unit waterlines. J Hosp Infect., 2005, 61(3): p. 257–262.
19. Mouchtouri, V.A., Goutziana, G., Kremastinou, J., Hadjichristodoulou, C. Legionella species colonization in cooling towers: risk factors and assessment of control measures. Am J Infect Control., 2010, 38(1): p. 50–55.
20. Stojek, N., Dutkiewicz, J. Legionella and other gram-negative bacteria in potable water from various rural and urban sources. Ann Agric Environ Med., 2006, 13(2), p. 323–335.
21. Boshuizen, H.C., Neppelenbroek, S.E., van Vliet, H., et al. Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease. J Infect Dis., 2001, 184(4), p. 515–518.
22. García-Fulgueiras, A., Navarro, C., Fenoll, D., et al. Legionnaires’ disease outbreak in Murcia, Spain. Emerg Infect Dis., 2003, 9(8): p. 915–921.
23. von Baum, H., Härter, G., Essig, A., et al. Preliminary report: outbreak of Legionnaires’ disease in the cities of Ulm and Neu-Ulm in Germany, December 2009 – January 2010. Euro Surveill., 2010, 15(4): pii=19472. Dostupný též na http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19472. [cit. 3-2-2012].
24. Juanita, A., Luqman, T., Dick, J.H., Arie, H.H. Infectious disease risks associated with occupational exposure: a systematic review of the literature. Occup Environ Med., 2012, 69, p. 140–146.
25. Sas, K. (Ed.) Legionella and legionnaires’ disease: a policy overview [on-line]. Dostupný na: osha.europa.eu/en/publications/literature_reviews/legionella-policy-overview.pdf. [cit. 3-2-2012].
26. Stout, J.E., Yu, V.L. Experiences of the first 16 hospitals using copper-silver ionization for Legionella control: implications for the evaluation of other disinfection modalities. Infect Control Hosp Epidemiol., 2003, 24(8), p. 563–568.
27. Strnad, V., Staňková, M., Misoň, P. První zkušenosti se sérologickou diagnostikou legionelózy v Československu. Čas Lék čes., 1982, 121(28), s. 865–869.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2012 Issue 4
Most read in this issue
- Asthma and nutrition: diet for the primary prevention and treatment of asthma
- Variants of human chromosomes and their significance from the point of view of clinical genetics
- What is the risk of disease caused by Legionella in the Czech Republic?
- The importance of histological verification of tumour metastasis